Appeal No. 1997-2188
Application 08/137,440
Claim 29. A method of treating memory dysfunction
characterized by decreased cholenergic [sic,
cholinergic] function which comprises administering
to a mammal an acetylcholinesterase inhibiting
amount of the compound of Claim 1.
Claim 30. A method of treating memory dysfunction
characterized by decreased cholinergic function
whith [sic, with] 6-O-demethylgalanthamine which
comprises administering to a mammal an acetyl-
cholinesterase inhibiting compound of Claim 4.
RELATED APPEALS
On page 3, lines 1 through 8 of their brief, appellants
direct our attention to two, related appeals which, according
to appellants, relate to the same issues as herein involved.
The related appeals involve U.S. Application Serial Number
08/137,443, filed on October 15, 1993 (Appeal Number 1997-
2182); and U.S. Application Serial Number 08/137,444, filed on
October 15, 1993 (Appeal Number 1997-2167).
The claims in this application differ from the claims in
the two related applications chiefly in the description of the
substituent R . Decisions in the two related appeals were2
mailed on even date with this opinion.
THE REJECTIONS
Claims 1 through 30 are rejected under 35 U.S.C. § 112,
first paragraph, on the grounds the specification fails to
5
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007